Table 5.
LYs and QALYs gained with QIV vs TIV in the models populated with best available data inputs.
| FLOU | FLORA | FLORENCE 1-year | FLORENCE lifetime | |
|---|---|---|---|---|
| Health outcomes gained (QIV vs. TIV) | ||||
| Life years gained | 8582 | 7352 | NA | 158,221 |
| LYs gained during time horizon | 0 | 0 | 0 | NA |
| LYs gained from deaths avoided | 8582 | 7352 | NA | NA |
| QALYs gained | 6832 | 6085 | NA | 123,837 |
| Baseline utilities | 0 | 0 | 0 | 115,407 |
| From influenza avoided | 310 | 326 | 342 | 5050 |
| From hospitalization avoided | 50 | 49 | 51 | 1045 |
| From outpatient Tx avoided | NA | 150 | 168 | 2335 |
| From deaths avoided | 6472 | 5560 | NA | NA |
QIV vs TIV, quadrivalent versus trivalent influenza vaccine; LY, life-year; QALY, quality-adjusted life-year; NA, not applicable; Tx, treatment.